PMID: 24353655Dec 20, 2013Paper

Prevalence of microvascular complications in newly diagnosed patients with type 2 diabetes

Pakistan Journal of Medical Sciences
Alia AliQasim Zafar Iqbal

Abstract

Microvascular complications are the major outcome of type 2 Diabetes Mellitus progression, which reduce the quality of life, incur heavy economic burdens to the health care system and increase diabetic mortality. The aims of this study were to assess the prevalence of microvascular complications among newly diagnosed type 2 diabetic patients and to analyze the association between these complications and poor glycemic control. This cross sectional hospital based study was carried out in Diabetic Clinic of Shaikh Zayed Postgraduate Medical Institute, Lahore Pakistan. The study was conducted from November 2011 to November 2012 among newly diagnosed type 2 diabetic patients. Relevant information of all patients was recorded with the help of a proforma. They were investigated for retinopathy, nephropathy and neuropathy. We have divided the patients into two groups: Group I with good glycemic control (HbA1c <6.5) and group II with poor glycemic control (HbA1c >6.5). In group II microvascular complications were 89.8%. Neuropathy, nephropathy and retinopathy were present in 68.5%, 56.2% and 31.4% respectively. These similar percentages in Group I were 50%, 0% and 31% respectively and are significantly lower. The study showed that even ...Continue Reading

Citations

Aug 14, 2019·Expert Review of Pharmacoeconomics & Outcomes Research·Shahid ShahAbid Shah
Jan 21, 2020·Journal of Diabetes Investigation·Suhad BahijriJaakko Tuomilehto
Jan 7, 2017·Journal of Diabetes Research·Luis Miguel Román-PintosErnesto Germán Cardona-Muñoz
Mar 5, 2021·Neuropsychiatric Disease and Treatment·Rasha Elbialy ElsharkawyNora Mohamed Ahmed Seliem
Jun 13, 2017·Diabetes & Metabolic Syndrome·N KotwalAmit Nachankar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.